Medical Marijuana, Inc., the parent organization of direct selling company Kannaway, announced it has appointed Blake Schroeder as the company’s new Chief Executive Officer and President. Schroeder will replace Dr. Stuart Titus, who is resigning as he prepares for semi-retirement. Following this transition, Dr. Titus will continue to function in a consulting role for the company, as well as a spokesperson and product and cannabis expert educator according to a multi-year contract.

“I am very pleased to see the Board of Directors select Blake for his new positions as I move towards semi-retirement,” said former Chairman and CEO Dr. Titus. “Blake has been the team leader over the company’s entire operations and responsible for fostering the re-emergence and growth of our company since coming on board with us in March 2016. The company is in very good hands with him at the helm. I’m also very excited to remain in my role as spokesperson, product expert and cannabis educator for the company. On a personal note, I am honored to have had the opportunity to be CEO of Medical Marijuana, Inc. and look forward to my continued role. Since our group founded this industry in 2011 my vision for CBD has become a reality with the amazing acceptance by the general public as well as the medical community. I continue to believe that almost everything in this industry remains at an early-stage, ground-floor level.”

Schroeder was formerly the CEO of Kannaway, whose annual sales reached almost $70 million in 2019 under his leadership. Schroeder also has extensive experience in regulatory oversight, global sales, product development, marketing, distribution and operations in the nutrition industry, and has overseen business development in countries across the globe.

“I am honored to take on these positions within our company,” said Chairman and CEO Blake Schroeder. “This is and always has been a ‘Company of Firsts’ and we owe much of our pioneering in the area of product development, market education and market acceptance of non-psychoactive cannabis products to the knowledge and insight of Dr. Titus. His continued role as our spokesperson is especially positive for the company.”